Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRCA1 and BRCA2 mutations in Belgian families with a history of breast and/or ovarian cancer.

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) - 1 Feb 1998

Sibille-Hoang C, Froment O, Joos de ter Beerst A, Lepiece V, Huberlant G, Blauwaert G, Vindevoghel A, Canon J L, Gillerot Y

Abstract excerpt

UNLABELLED: Certain familial breast and/or ovarian cancers, specially those diagnosed early, are dominantly heritable and have been linked to mutations in BRCA1 and BRCA2 genes. We have tested 30 women selected from 25 different families with specific criteria. Blood samples were always taken with the informed consent and preliminary interview of the patient by a physicologist specialized in presymptomatic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Belgium
Share to BRCA2 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Genes, BRCA1

Share to Mutation

Share to Neoplasm Proteins

Share to Ovarian Neoplasms

Share to Transcription Factors

Source

Identifiers

PMID: 10866028
DOI: 10.1097/00008469-199802001-00002

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRCA1 and BRCA2 mutations in Belgian families with a history of breast and/or ovarian cancer.PMID 10866028Read ↗

BRCA1 and BRCA2 germline mutation spectrum and frequencies in Belgian breast/ovarian cancer familiesSemantic proximity Read ↗

A BRCA2 mutation, 4088insA, in a Finnish breast and ovarian cancer family associated with favourable clinical course.Semantic proximity Read ↗

BRCA1/2 mutations in Swiss patients with familial or early-onset breast and ovarian cancer.Semantic proximity Read ↗

BRCA1 and BRCA2 genes: role in hereditary breast and ovarian cancer in Italy.Semantic proximity Read ↗

High frequency of BRCA1/2 germline mutations in 42 Belgian families with a small number of symptomatic subjects.Semantic proximity Read ↗

Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients.Semantic proximity Read ↗

[Rapid detection of BRCA-1 germline mutations by the protein truncation test in Tunisian families].Semantic proximity Read ↗

BRCA1-related breast cancer in Austrian breast and ovarian cancer families: specific BRCA1 mutations and pathological characteristics.Semantic proximity Read ↗

Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast and/or ovarian cancer families in Southern Germany.Semantic proximity Read ↗

[Analysis of mutations in genes BRCA1 and BRCA2 among patients with breast and ovarian cancer in northern Portugal and Galicia].Semantic proximity Read ↗

Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer.Semantic proximity Read ↗

[Determination of a BRCA1 gene mutation in a family with hereditary breast cancer].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.